Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2022-03-04
2022-06-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motivating Increases in Physical Activity for Prevention of Weight Regain After Metabolic Bariatric Surgery
NCT06484621
ACTyourCHANGE Study Protocol. Promoting Healthy Lifestyle With ACT for Obesity
NCT04474509
Acceptance Based Behavioral Intervention for Weight Loss: A Randomized Trial
NCT01461421
Behavioral Weight Loss Treatment for Individuals With Food Addiction
NCT04311450
Enhancing Memory to Facilitate Weight Loss: Tracking, Recording and Coaching
NCT03446729
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
Participants in the experimental group received ACT training in the group setting aiming to reduce weight-related experiential avoidance. This included 6 sessions in total. Each session was completed approximately in 80 mins.
ACT for weight-related experiential avoidance
Participants in the experimental group received weight concern-related ACT training in a group setting. Each session focused on different dimensions of ACT and included relevant exercises and homeworks. Dimensions studied included creative hopelessness, control strategies, mindfulness exercises, values and barries to values and commitment to action.
Control group
Participants in the control group did not receive any manipulation
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ACT for weight-related experiential avoidance
Participants in the experimental group received weight concern-related ACT training in a group setting. Each session focused on different dimensions of ACT and included relevant exercises and homeworks. Dimensions studied included creative hopelessness, control strategies, mindfulness exercises, values and barries to values and commitment to action.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to read and understand Turkish
Exclusion Criteria
* and those who were diagnosed with an eating disorder were excluded from the analyses
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bahcesehir Cyprus University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Buse Keskindag
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Meryem Karaaziz, PhD
Role: STUDY_DIRECTOR
Near East University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Near East University
Nicosia, , Cyprus
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Pearson, Adria N., Victoria M. Follette, and Steven C. Hayes.
Related Links
Access external resources that provide additional context or updates about the study.
Protocol of this study was adapted with permission of corresponding author
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NEU/SS/2022/1208
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.